1-Bromo-4-phenylbutan-2-one | CAS:31984-10-8

We serve 1-Bromo-4-phenylbutan-2-one CAS:31984-10-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-4-phenylbutan-2-one

Chemical Name:1-Bromo-4-phenylbutan-2-one
CAS.NO:31984-10-8
Synonyms:1-Bromo-4-phenylbutan-2-one
1-bromo-4-phenyl-2-butanone
1-bromo-4-phenyl-butan-2-one
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 290.1±15.0 °C at 760 mmHg
Molecular Formula C10H11BrO
Molecular Weight 227.098
Flash Point 70.6±7.7 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.551
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bimatoprost(CAS:155206-00-1) and Latanoprost(CAS:130209-82-4).



Contact us for information like 1-Bromo-4-phenylbutan-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-bromo-4-phenyl-butan-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-4-phenylbutan-2-one Use and application,1-Bromo-4-phenylbutan-2-one technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.(+)-Dibenzoyl-D-tartaric acid manufacturer New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country.(R)-1-(naphthalen-1-yl)ethanamine supplier Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.2-Fluoro-4-(methoxycarbonyl)phenylboronic acid vendor The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.